Clinical Trials Browser

Phase 1 × BHQ880 × Plasma cell × Clear all

NCT00741377 2013-02-18

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Phase 1 Completed

Bone Diseases, Multiple Myeloma